Oral Mucositis in Newly Diagnosed Head and Neck Cancers Clinical Trial


Study Information

Study Title

ROMAN: Reduction in Oral Mucositis with Avasopasem Manganese (GC4419) – Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer

Study Summary

The purpose of the phase 3, clinical study is to determine if GC4419 administered prior to intensity-modulated radiation therapy (IMRT) reduces the severity of radiation induced oral mucositis in patients who have been diagnosed with locally advanced, non-metastatic squamous cell carcinoma of the head and neck.

Principal Investigator

Dr. Waqas Rehman

Phase III

For more information visit this site

If you have any questions regarding this study or think that you or your loved one may be eligible, please contact our Clinical Trial Coordinator by dialing 908.237.2330 extension 2.

Contact HHO

All questions and feedback are welcome, anytime.






    About HHO


    Hunterdon Hematology Oncology is a community oncology group, dedicated to fighting cancer in this community and across the region. Our Doctors, Physician’s Assistants and Nurses work tirelessly. They fight hard so that you can win.




    Subscribe


    Sign up for the HHO newsletter to stay up to date on the latest news within the practice and the community.



      © HHO 2022. All rights reserved. Designed by DRAW